UBE2K expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.885600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.915600E-01
Normal-vs-Stage2
6.080200E-01
Normal-vs-Stage3
5.197400E-01
Normal-vs-Stage4
3.177400E-01
Stage1-vs-Stage2
9.008200E-01
Stage1-vs-Stage3
2.336200E-01
Stage1-vs-Stage4
3.085000E-01
Stage2-vs-Stage3
1.765800E-01
Stage2-vs-Stage4
1.904380E-01
Stage3-vs-Stage4
1.581560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.920000E-01
Normal-vs-AfricanAmerican
5.061000E-01
Normal-vs-Asian
9.613800E-01
Caucasian-vs-AfricanAmerican
6.464400E-01
Caucasian-vs-Asian
3.620000E-01
AfricanAmerican-vs-Asian
3.683400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.587600E-01
Normal-vs-Female
5.022200E-01
Male-vs-Female
4.387000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.017600E-01
Normal-vs-Age(41-60Yrs)
2.891000E-01
Normal-vs-Age(61-80Yrs)
7.296000E-01
Normal-vs-Age(81-100Yrs)
9.230800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.720000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.393000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.259600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.194400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.983900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.839600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.791800E-01
Normal-vs-Daily Drinker
8.989000E-01
Normal-vs-Weekly Drinker
8.182400E-01
Normal-vs-Occasional Drinker
1.301640E-01
Normal-vs-Social Drinker
6.106600E-01
Non Drinker-vs-Daily Drinker
9.598400E-01
Non Drinker-vs-Weekly Drinker
8.655800E-01
Non Drinker-vs-Occasional Drinker
6.598400E-03
Non Drinker-vs-Social Drinker
5.279000E-01
Daily Drinker-vs-Weekly Drinker
8.403800E-01
Daily Drinker-vs-Occasional Drinker
9.403400E-03
Daily Drinker-vs-Social Drinker
5.184400E-01
Weekly Drinker-vs-Occasional Drinker
3.595900E-02
Weekly Drinker-vs-Social Drinker
7.025000E-01
Occasional Drinker-vs-Social Drinker
6.073800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.711400E-01
Normal-vs-Grade 2
7.722600E-01
Normal-vs-Grade 3
7.311000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.631000E-01
Grade 1-vs-Grade 3
7.191400E-01
Grade 1-vs-Grade 4
4.711400E-01
Grade 2-vs-Grade 3
3.537600E-01
Grade 2-vs-Grade 4
7.722600E-01
Grade 3-vs-Grade 4
7.311000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.489600E-01
Normal-vs-NonDiabetic
5.764200E-01
Diabetic-vs-NonDiabetic
1.124640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.937000E-01
Normal-vs-NoPancreatitis
6.668000E-01
Pancreatitis-vs-NoPancreatitis
6.783000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.342600E-01
Normal-vs-N1
5.935200E-01
N0-vs-N1
6.979600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.798590E-01
Normal-vs-TP53-NonMutant
7.231400E-01
TP53-Mutant-vs-TP53-NonMutant
2.777900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
